Robinhood Markets has stabilised at $93.51 after last week's 13% earnings-driven collapse, but the analyst community's response to the July 29 print tells a more complex story: bullish ratings intact, price targets cut across the board.
The Street's reaction to earnings was uniform in direction, if not in magnitude. Goldman Sachs lowered its target from $137 to $118 while keeping Buy. Barclays trimmed from $122 to $105, maintaining Overweight. Cantor Fitzgerald followed suit this week, cutting from $130 to $115 while holding Overweight. Needham brought its target down to $120 from $123. The pattern is consistent: every firm that moved post-earnings went lower on the target, but none pulled their bullish rating. The consensus mean now sits at $119.82 — still 28% above the current price. That gap was 28% heading into earnings too, which means the print resolved nothing in terms of the valuation disconnect. The analyst recommendation differential factor score ranks at the 91st percentile, reflecting just how lopsidedly constructive the Street remains. Citizens and BTIG held their targets unchanged at $155 and $125 respectively, suggesting the upper end of the bull case is still very much alive on the Street.
The earnings reaction itself bears noting. The stock fell 6.6% the day after the July 29 print — consistent with a pattern of post-result weakness. That matches the previous comparable event, where the stock dropped 8.7% the following day and shed another 7.7% over the subsequent five sessions. This time the damage was concentrated in a single week, with the stock bottoming near $90 before recovering. The bounce to $93.51 — up 3.5% on Tuesday — is the first sign of stabilisation, though the stock remains down 17% on the month.
Short interest has nudged higher since the print, rising 3.3% on the week to 4.85% of the free float — edging back toward the early-July levels around 5.1% but well below those peaks. That is a mild rebuild, not an aggressive repositioning. The borrow market offers no amplifying pressure: availability runs above 1,100% of outstanding short interest, meaning there are roughly eleven shares available to lend for every one currently borrowed. Cost to borrow has eased 20% on the week to 0.45% — among the cheapest in the market. Options positioning is similarly relaxed, with the put/call ratio at 0.63, marginally below its 20-day average and near a one-standard-deviation underweight on protective hedging. The short score of 37.9 places HOOD in the lower half of the universe on squeeze potential. Overall, positioning looks calm rather than charged — no sign of a forced unwind, no sign of building conviction on the bear side either.
Insider activity adds a note of caution. Co-founder Baiju Bhatt sold just over $4.7 million of stock on July 24, across multiple tranches at prices between $93 and $99. CFO Shiv Verma sold a further $456,000 at prices around $113–$116 on July 15, while the stock was trading above current levels. The 90-day net insider position is technically a small net positive at roughly 479,000 shares, but the recent transactional activity has been entirely on the sell side from the company's two most prominent insiders. That does not constitute an alarm, but it does mean the stock's recovery is happening without any offsetting signal from the people who know the business best.
The valuation picture has compressed meaningfully. The price-to-earnings multiple has fallen roughly 12 points over the past 30 days to 31.3x, and price-to-book has declined by about 2.5 turns to 6.8x. EPS momentum remains a genuine bright spot — ranking in the 90th percentile on a 30-day basis and the 96th percentile over 90 days — which is the clearest fundamental support for the bull case. Among close peers, BULL gained 4.3% on the week while COIN fell 10.2% and IBKR slipped 2.5%, suggesting the fintech space is not moving in unison and that HOOD's stabilisation is at least partially stock-specific rather than a sector tailwind.
The next earnings event is not until November 4, leaving three months for the market to decide whether the $120 consensus target is a destination or a relic — and whether the current 28% discount to Street estimates is opportunity or a warning sign that analysts are slow to reprice.
See the live data behind this article on ORTEX.
Open HOOD on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
